Navigation Links
Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
Date:5/27/2009

THE WOODLANDS, Texas, May 27 /PRNewswire-FirstCall/ --Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving oral presentations on two of its clinical-stage drug development programs: LX1031, an oral drug candidate for the treatment of irritable bowel syndrome (IBS), and LX1032, an oral drug candidate for managing gastrointestinal symptoms associated with carcinoid syndrome. The presentations will take place at Digestive Disease Week (DDW) in Chicago, Illinois on Sunday, May 31 and Monday, June 1, respectively. DDW is the world's largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. LX1031 is currently in a Phase 2 clinical trial in patients with non-constipating IBS, and LX1032 is entering a Phase 2 study in patients with carcinoid syndrome.

For more information on these programs and to download both presentations (available after June 1), please visit www.lexpharma.com.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease,
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
2. Lexicon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. Lexicon Appoints Judith Swain, M.D. to Board of Directors
4. Lexicon Pharmaceuticals to Present at ThinkEquity ThinkClinic
5. Lexicon Pharmaceuticals to Present at Bio InvestorForum
6. Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007
7. Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results
8. Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
9. Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
10. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
11. Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... announces that a new market research report ... Carbondioxide Incubators - A Global Market Perspective ... Incubators are the most critical equipment used ... applications for providing a controlled environment to ...
(Date:12/2/2009)... demonstration tires made with BioIsoprene technology, a ... the manufacture of synthetic rubber with renewable biomass, made ... will be on display at a lounge in the ... December 21, while the other tire will make appearances ...
(Date:12/2/2009)... Gabon, December 2 , ... and Heritage" , Coinciding ... 2010 the,Gabonese Republic is hosting an international conference ... resources in Africa. The,conference will be attended by ...
(Date:12/2/2009)... 2 Gamida Cell announced today,a feasibility study ... a gene therapy product which combines technology from ... may have potential to,treat inherited anemias such as ... Cell is developing a series of technologies to ...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
... Marketing and Sales; Susan Koppy ... President, Corporate Development, PT. RICHMOND, Calif., July 2 ... the position of,Vice President, Marketing and Sales and Susan Koppy ... and Ms. Koppy will report,to President & Chief Executive Officer ...
... manufactured from bone marrow; SV Life ... LAKE CITY and HAMBURG, Germany, July 2 AlloCure,Inc., ... therapies,for the treatment of acute kidney injury, today announced ... was led by SV Life Sciences with Novo,A/S joining ...
... Aureus Pharma, a leading provider of,knowledge management solutions ... today that the Aureus Pharma 2008 User Symposium ... 24th., This symposium follows last year,s highly ... Aureus, pharmaceutical and biotech customers,from both Europe and ...
Other Biology Technology:Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Aureus Pharma Announces Date of 2008 Annual User Symposium 2
(Date:12/3/2009)... social snubbing? Your genetics, not your friends, may be at ... opioids, relieve not only physical pain, but also some forms ... of 1000 Biology member Markus Heilig shows that small genetic ... the intensity of people,s responses to social rejection. , ...
(Date:12/3/2009)... of scientists from the U.S. Department of Energy,s (DOE) ... of Science has made a major step in understanding ... is necessary to carry out important biological processes. The ... Nature Structural & Molecular Biology , confirms that ...
(Date:12/2/2009)... results strengthen the evidence that people who smoke cigarettes ... risk for developing colorectal cancer, even after adjusting for ... reason not to smoke, or to quit as soon ... M.S., vice president emeritus, epidemiology and surveillance research at ...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 1Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 2Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 3HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1Kendle to Present at UBS Global Life Sciences Conference 14090 1Kendle to Present at UBS Global Life Sciences Conference 14090 2
... from what a runner might take on a jog, ... make life more comfortable for cattle. , A jogger,s ... pedometer are a few of the tools K-State researchers ... routine procedures, castration and dehorning. , Hans Coetzee, assistant ...
... that are embedded in their cell walls. For the ... the plasmodesmata are lifelines, allowing nutrients and genetic instructions ... cues trigger changes in the structure of the tiny ... The genes and molecular pathways of the plant cell ...
... University March 2-3 to discuss engineering solutions to major ... to education and energy. , The summit is in ... http://www.engineeringchallenges.org/ ) issued last year by the National Academy ... will play a critical part in resolving major societal ...
Other Biology News:Veterinarians developing model to help producers, vets make cattle more comfortable 2Veterinarians developing model to help producers, vets make cattle more comfortable 3CSHL researchers identify gene that helps plant cells keep communication channels open 2CSHL researchers identify gene that helps plant cells keep communication channels open 3Duke forum to address global engineering problems 2
... Rapid, efficient extraction of DNA from agarose gels ... of DNA fragments of 150 bp to > 12,000 ... GelMelt solution to dissolve the gel slice, followed by ... a spin column format. After a wash step, the ...
Fujifilm BAS-1800II provides the ideal configuration for a low-cost imager that requires only a small amount of space in the laboratory. The small imager for accurate high-throughput screening...
When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
... a compact and self-contained multichannel pipettor. ... unique flow-through device, which allows extremely ... system. Optional refill system and ... Will be upgradable to with Tecans ...
Biology Products: